BRUSSELS (Reuters) - EU antitrust regulators will widen a probe into Zimmer Holdings Inc's $13.4 billion bid for Biomet Inc [LVBHAB.UL] but clear Eli Lilly's offer for a Novartis AG unit, three people familiar with the matter said on Thursday.
Reuters: Business News, Reuters: Business
Thu, 10/02/2014 - 6:49am